Pierre Blanchard

Pierre Blanchard: 10 year results of HYPO RT PC at ESTRO 2025

Pierre Blanchard, Radiation Oncology Clinical Section Chief at Gustave Roussy Cancer Institute, shared a post on X:

“10y results of HYPO RT PC at ESTRO 2025

Hypofractionated prostate cancer RT (42,7/7) vs conv fractionated RT

1. Non inferior for FFS (even better?)
2. Similar bPFS, DMFS, ADT use, OS
3. Similar GU/GI tox (except transient flare at 1y for UHF).”

Pierre Blanchard

ESTRO 2025 Live Updates on OncoDaily.

HYPO-RT-PC Phase III trial: Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for Prostate Cancer, After 10-Year Follow-Up

cancer ESTRO ESTRO 2025 ESTRO25 OncoDaily Oncology Pierre Blanchard